Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.

[1]  G. Moneta,et al.  Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke , 2009 .

[2]  Ronald G. Thomas,et al.  Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study , 2008, The Lancet Neurology.

[3]  L. Pettigrew,et al.  Telephonic guidance of systemic thrombolysis in acute ischemic stroke: Safety outcome in rural hospitals , 2008, Clinical Neurology and Neurosurgery.

[4]  Bernadette Boden-Albala,et al.  Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. , 2007, Annals of emergency medicine.

[5]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[6]  G. Albers,et al.  Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors , 2007, Cerebrovascular Diseases.

[7]  P. Heuschmann,et al.  Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany , 2006, The Lancet Neurology.

[8]  L. McCullough,et al.  The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. , 2005, Connecticut medicine.

[9]  California Acute Stroke Pilot Registry Investigators.  Prioritizing interventions to improve rates of thrombolysis for ischemic stroke , 2005 .

[10]  M. Flaster,et al.  tPA by telephone: Extending the benefits of a comprehensive stroke center , 2005, Neurology.

[11]  P. Heuschmann,et al.  Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. , 2004, JAMA.

[12]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[13]  Joseph P Broderick,et al.  Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Population-Based Study , 2004, Stroke.

[14]  G. D. Graham,et al.  Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data , 2003, Stroke.

[15]  D. Summers,et al.  Expanded Modes of Tissue Plasminogen Activator Delivery in a Comprehensive Stroke Center Increases Regional Acute Stroke Interventions , 2003, Stroke.

[16]  M. Hammer,et al.  Quality Improvement and Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Cleveland Update , 2003, Stroke.

[17]  J. Concato,et al.  Thrombolysis for acute stroke in routine clinical practice. , 2002, Archives of internal medicine.

[18]  V. Hachinski,et al.  Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients , 2002, Stroke.

[19]  S. Cramer,et al.  Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals , 2001, Stroke.

[20]  A. Furlan,et al.  Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. , 2000, JAMA.

[21]  J. Milbrandt,et al.  Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. , 2000, Stroke.

[22]  L Bozzao,et al.  Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.

[23]  J. Chalela,et al.  Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. , 1999, Stroke.

[24]  J. Grotta,et al.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1996, Stroke.

[25]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[26]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .